Abbott Laboratories (ABT): Daniel Gesua Sive Salvadori , Senior Vice President of Abbott Laboratories sold 815 shares on Sep 26, 2016. The Insider selling transaction was reported by the company on Sep 28, 2016 to the Securities and Exchange Commission. The shares were sold at $41.71 per share for a total value of $33,994.46 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 29, 2016, Stephen R Fussell (Executive Vice President) sold 41,500 shares at $45.01 per share price.On Jul 27, 2016, Robert E Funck (Vice President, Controller) sold 26,800 shares at $43.08 per share price.Also, On Jul 27, 2016, Michael J Warmuth (Executive Vice President) sold 26,800 shares at $43.49 per share price.On Jul 27, 2016, Miles D White (CEO) purchased 17,933 shares at $43.34 per share price.
Abbott Laboratories: On Tuesday, Sep 27, 2016 heightened volatility was witnessed in Abbott Laboratories which led to swings in the share price. The shares opened for trading at $41.71 and hit $42.335 on the upside , eventually ending the session at $42.33, with a gain of 1.56% or 0.65 points. The heightened volatility saw the trading volume jump to 59,64,927 shares. The 52-week high of the share price is $46.38 and the company has a market cap of $62,225 M . The 52-week low of the share price is at $36.
On Sep 15, 2016, Abbott Laboratories announced a cash dividend of $0.2600. The company’s management has announced Oct 12, 2016 as the ex-dividend date and fixed the record date on Oct 14, 2016. The payable date has been fixed on Nov 15, 2016.
Abbott Laboratories (Abbott) is engaged in the discovery development manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products Diagnostic Products Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks hospitals commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary endovascular structural heart vessel closure and other medical device products.